Phase I Clinical Study of HY01 in Patients

NCT04961099 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Sudden Sensorineural Hearing Loss

Interventions

DRUG: HY01

Sponsor

Heyu (Suzhou) Pharmaceutical Technology Co., Ltd